YuJa | November 28, 2022
Franciscan University is enhancing teaching and learning and boosting the digital accessibility of its content through its agreement with YuJa, Inc., a leader in ed-tech solutions. The Steubenville, Ohio, university has implemented both YuJa Enterprise Video Platform and YuJa Panorama to complement Canvas, its learning management system (LMS). Initially, the institution was seeking a replacement video recording and editing, media management, and quizzing solution for Vidgrid, which is phasing out its education offerings. It was through a pilot program that Franciscan University recognized that YuJa Enterprise Video Platform and YuJa Panorama would seamlessly integrate with its LMS, improving accessibility across the Canvas platform and amplifying recordings, media management and quizzing to provide the tools for every student to succeed.
“The Video Platform’s built-in accessibility features are enhanced by YuJa Panorama, Each product works as a standalone offering or combines to help deliver engaging video and media content. We’re excited for the Franciscan University community to leverage the capabilities to create an even more powerful teaching and learning experience.”
Nathan Arora, Chief Business Office at YuJa Inc.
ABOUT FRANCISCAN UNIVERSITY
Founded in 1946, Franciscan University of Steubenville is no ordinary university, and a Franciscan education is no ordinary education. It is an education as rigorous and demanding as it is faithful-an education that challenges its students intellectually, forms them professionally, and feeds them spiritually. The university has more than 3,000 students in 40 undergraduate and eight graduate degree programs. The student body is 97 percent Catholic, and the university has the largest number of students majoring in theology, catechetics, and philosophy of any Catholic university in the United States.
ABOUT YUJA, INC.
YuJa is a leader in ed-tech solutions. Our platforms provide organizations of all sizes with the tools to educate, engage, inspire and collaborate. We serve learning enterprises within all sectors, including higher-ed, K-12, government, healthcare, non-profit and corporate. We have legal headquarters in Delaware with primary U.S. offices in Silicon Valley, California, and Canadian offices in Toronto.
Milton Hershey School | November 14, 2022
Catherine Hershey Schools for Early Learning (CHS) announced yesterday at an event at Eden Resort & Suites in Lancaster, Pennsylvania, that it will open three Early Childhood Education Centers (ECECs) in Lancaster County to serve children from birth to age 5 from economically disadvantaged and at-risk backgrounds. The cost-free Centers will be located in Lancaster City, New Danville, and Elizabethtown. At yesterday's event, Lancaster County community leaders and child advocates heard from CHS and Milton Hershey School (MHS) leadership about their approach to providing accessible early childhood education. CHS intends to support and work collaboratively with existing Lancaster County organizations to serve local children and families. City of Lancaster Mayor Danene Sorace also spoke, explaining how the addition of the CHS Centers will positively impact the broader Lancaster County community. The three CHS Centers in Lancaster County are part of a $350 million initiative to initially develop six ECECs in the state as subsidiaries of MHS. Each will offer a non-residential, year-round core early learning program with a curriculum designed to enhance children's educational, social, and emotional development. It also will provide children with nutritious meals, transportation, and other needed supplies, along with integrated support services to families of enrolled children. All of this will be provided with all costs covered to qualifying families. Yesterday's announcement was suitably made during Founders Week at MHS, which celebrates the anniversary of Milton and Catherine Hershey establishing the school 113 years ago. The Hersheys' legacy is deeply rooted in Lancaster County, making this expansion especially meaningful. Milton Hershey spent his childhood in Bart Township and, as an adult, opened the Lancaster Caramel Company. Lancaster County is also where Milton and Catherine Hershey spent the early years of their marriage and invested in the Lancaster community through their support of St. Joseph's Hospital, Franklin & Marshall College, and Catherine's service as an inaugural member of the Lancaster Charity Society.
The Lancaster County CHS Centers are expected to begin opening in 2026.
ABOUT CATHERINE HERSHEY SCHOOLS FOR EARLY LEARNING
Catherine Hershey Schools for Early Learning will provide a cost-free educational, social, and cognitive program to children from birth to age 5 from economically disadvantaged and at-risk backgrounds through the development of initially six Early Childhood Education Centers. The Centers are subsidiaries of Milton Hershey School and will be staffed and operated independently of the Milton Hershey School core model. For more information, visit chslearn.org.
ABOUT MILTON HERSHEY SCHOOL
Milton Hershey School is one of the world's best private schools, where qualifying students in pre-kindergarten through 12th grade live on campus and receive an exceptional educational experience—with all costs covered.
Manchester University | November 03, 2022
GenXys, the global leader in precision prescribing software with embedded pharmacogenetic (PGx) data, is teaming up with Manchester University (MU) for pharmacogenomics education. Together, GenXys and MU will help drive global awareness and education of PGx-informed prescribing decisions in support of expanding PGx adoption and pending legislation in the U.S., including the Right Drug Dose Now Act. MU, located in northern Indiana, is a leading national academic institution with a strong educational and research stream in pharmacogenetics. With on-campus, online, and dual (PharmD/MS in PGx) degree programs, as well as a Graduate Certificate in PGx, MU typically has an annual PGx enrollment of 60 to 70 students. The partnership will enable GenXys' expertise and proprietary algorithms in genomics and clinical knowledge to support the expansion of genetically informed medication review capabilities in MU's educational and research space. MU will now be able to integrate GenXys' award-winning Clinical Decision Support Systems (CDSS), incorporating PGx with other patient data points through embedded translation and interpretation in specific degree programs. This will lead to students further learning appropriate evidence-based precision prescribing options for patients, ultimately leading to better health outcomes and empowering the next generation of clinicians to seamlessly utilize PGx in patient care. As a national leader in pharmacogenetic and clinical education, Manchester University looks to partner with leading-edge technology companies that further the advancement of PGx for better health outcomes, says David Kisor, PharmD, FCP, Professor of Pharmaceutical Sciences and Pharmacogenomics, Director of Pharmacogenomics at MU. "It is recognized that more than 95 percent of the population has at least one PGx variant, and large percentages of patients receiving medications across therapeutic areas do not respond adequately with an initial medication leading to trial-and-error prescribing. Additionally, the consequences and treatments of adverse drug events may cost more than $30 billion annually in the U.S.," Dr. Kisor adds. "By formally measuring the effect of automatic PGx inclusion in CDSS tools in education as well as incorporating GenXys' precision prescribing platform into our advanced courses, we aim to produce the most knowledgeable and equipped individuals who will apply PGx optimally across healthcare settings. Integration of the precision prescribing platform offered by GenXys into the educational content of MU will accelerate the knowledge uptake of PGx in prescribing decisions for the next generation of clinicians and other healthcare professionals.
"By working with a stellar academic university like MU, we are able to demonstrate the advantage of including PGx in clinical care for clinicians across different career levels ,There are so many advantages to equipping students and trainees with leading-edge tools and knowledge—the future is looking bright for precision medicine!"
Bernard Esquivel, MD, PhD, Chief Medical Officer of GenXys.
Auto-analysis of genetic information with other medication interaction points is helping to transform the centuries-old trial-and-error approach to prescribing to one of accuracy. PGx is all about personalized, safe, and appropriate medication options being available at any point of care. When integrated into smart algorithms with other data points, PGx is a critical part of proactive healthcare delivering precision medicine to everyone and leveling up healthcare inequality. MU is at the educational edge of changing day-to-day healthcare, and the partnership with GenXys is a model of commercial and academic integration that supports pending national legislation to provide better population healthcare, improve patient safety, and reduce healthcare costs.
About GenXys Health Care Systems
GenXys, with a presence across North America, provides the world's most comprehensive precision prescribing solutions with embedded pharmacogenetics to solve one of healthcare's biggest challenges: inappropriate ("trial-and-error") prescribing. GenXys' clinical decision support software suite is in use by major insurance providers, health systems, pharmacies and their pharmacogenetic labs across North America. Ongoing global clinical studies are paving the way into geographical markets to enable GenXys to realize its vision of making every prescription better with its software to increase patient safety, improve population health, and reduce healthcare costs. https://www.genxys.com/
About Manchester University
Manchester University, in North Manchester and Fort Wayne, Ind., provides vibrant and transformative student experiences. Manchester University respects the infinite worth of every individual and graduates persons of ability and conviction who draw upon their education and faith to lead principled, productive, and compassionate lives that improve the human condition.